首页 › 基金 › Jupiter Topco LLC › PCVX
Jupiter Topco LLC 对 PCVX 的持仓历史
VAXCYTE INC · 医疗保健
Jupiter Topco LLC 在 Q2 2026 的 13F 申报中披露持有 PCVX(VAXCYTE INC)17,965,847 股,市值约 US$1.04B,约占其申报组合的 0.43%,在其申报持仓中市值排名第 42 位。 Jupiter Topco LLC 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR
Jupiter Topco LLC 对 PCVX 的持仓演变
Jupiter Topco LLC 于 Q2 2026 首次披露 PCVX 持仓:17,965,847 股(约 US$1.04B)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 17.97M | $1.04B | 新进 |
关于 PCVX 与 13F 数据
PCVX(VAXCYTE INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 PCVX,申报仓位最大的包括:骏利亨德森集团 (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M), RA CAPITAL MANAGEMENT, L.P. (US$667.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PCVX 的基金
- 骏利亨德森集团 16.58M 股 · $960.23M · Q1 2026
- T. Rowe Price Investment Management, Inc. 12.21M 股 · $709.62M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 11.47M 股 · $667.02M · Q2 2026
- Deep Track Capital, LP 4.30M 股 · $249.96M · Q2 2026
- Kynam Capital Management, LP 2.92M 股 · $169.88M · Q2 2026
- Caligan Partners LP 2.19M 股 · $127.23M · Q2 2026
- Paradigm Biocapital Advisors LP 2.13M 股 · $123.69M · Q2 2026
- Bellevue Group AG 1.97M 股 · $114.63M · Q2 2026
- Maverick 资本 1.61M 股 · $93.78M · Q2 2026
- MAVERICK CAPITAL LTD 1.61M 股 · $93.78M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.43M 股 · $82.86M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.38M 股 · $80.23M · Q2 2026
更多关于 Jupiter Topco LLC
常见问题
How long has Jupiter Topco LLC held PCVX?
Jupiter Topco LLC has disclosed PCVX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Jupiter Topco LLC's current position in PCVX?
As of Q2 2026, Jupiter Topco LLC holds 17.97M shares of PCVX (VAXCYTE INC), valued at $1.04B, representing 0.43% of its reported portfolio and ranking #42.
Has Jupiter Topco LLC been buying or selling PCVX?
In the latest 13F filing (Q2 2026), Jupiter Topco LLC newly opened its position in PCVX.
Which other funds hold PCVX?
Other major institutional holders of PCVX include 骏利亨德森集团, T. Rowe Price Investment Management, Inc., RA CAPITAL MANAGEMENT, L.P., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.